Opsens Stock Forecast, Price & News

+0.26 (+14.26 %)
(As of 07/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume1.32 million shs
Average Volume63,469 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive OPSSF News and Ratings via Email

Sign-up to receive the latest news and ratings for Opsens and its competitors with MarketBeat's FREE daily newsletter.

Opsens logo

About Opsens

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in two segments, Medical and Industrial. The Medical segment primarily focuses on physiological measurement, such as FFR and dPR in the coronary artery stenosis market; and supplies a range of miniature optical sensors to measure pressure and temperature used in integrated applications in other medical devices, as well as licenses its optical sensor technology. The Industrial segment develops, manufactures, and installs fiber optic sensing solutions for industrial applications. The company offers OptoWire, an advanced optical-based pressure guidewire that enhances the clinical outcome of patients with coronary artery disease; and OptoMonitor. It also provides fiber optic temperature sensors, pressure sensors, strain sensors, displacement sensors, and extensometers, as well as signal conditioners/OEM boards. It serves various markets, such as life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and other markets. The company sells its products through a direct sales force to distributors in the United States, Japan, Canada, and internationally. The company is headquartered in Québec, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.43 out of 5 stars

Analyst Opinion: 2.5Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Opsens (OTCMKTS:OPSSF) Frequently Asked Questions

Is Opsens a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Opsens in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Opsens stock.
View analyst ratings for Opsens
or view top-rated stocks.

What stocks does MarketBeat like better than Opsens?

Wall Street analysts have given Opsens a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Opsens wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Opsens?

Opsens saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 14,700 shares, an increase of 32.4% from the May 31st total of 11,100 shares. Based on an average trading volume of 18,500 shares, the days-to-cover ratio is currently 0.8 days.
View Opsens' Short Interest

How were Opsens' earnings last quarter?

Opsens Inc. (OTCMKTS:OPSSF) posted its earnings results on Tuesday, January, 21st. The company reported ($0.01) EPS for the quarter.
View Opsens' earnings history

How has Opsens' stock price been impacted by COVID-19 (Coronavirus)?

Opsens' stock was trading at $0.5135 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, OPSSF stock has increased by 305.6% and is now trading at $2.0830.
View which stocks have been most impacted by COVID-19

What price target have analysts set for OPSSF?

3 brokerages have issued 12 month price targets for Opsens' stock. Their forecasts range from $2.25 to $2.75. On average, they expect Opsens' share price to reach $2.50 in the next year. This suggests a possible upside of 20.0% from the stock's current price.
View analysts' price targets for Opsens
or view top-rated stocks among Wall Street analysts.

Who are Opsens' key executives?

Opsens' management team includes the following people:
  • Mr. Alan W. Milinazzo, Exec. Chairman (Age 61, Pay $86.03k)
  • Mr. Louis Laflamme CPA, C.A., CPA, Pres, CEO & Director
  • Mr. Robin Villeneuve C.A., CPA, CFO & Corp. Sec. (Age 54, Pay $188.3k)
  • Mr. Pierre Poulin, Corp. Controller

Who are some of Opsens' key competitors?

What is Opsens' stock symbol?

Opsens trades on the OTCMKTS under the ticker symbol "OPSSF."

How do I buy shares of Opsens?

Shares of OPSSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Opsens' stock price today?

One share of OPSSF stock can currently be purchased for approximately $2.08.

How many employees does Opsens have?

Opsens employs 171 workers across the globe.

What is Opsens' official website?

The official website for Opsens is opsens.com.

How can I contact Opsens?

The company can be reached via phone at 418-781-0333.

This page was last updated on 7/31/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.